Professor of Medicine
University of Oklahoma Health Sciences Center
Oklahoma City, Oklahoma, United States
Dr. Baber is an Assistant Professor of Medicine at the Icahn School of Medicine at Mount Sinai and also serves as the Director of Clinical Biometrics in the Office of Interventional Cardiovascular Research and Clinical Trials within the Cardiovascular Institute at Mount Sinai. Dr. Baber’s primary research interests center on the outcomes and treatment of high-risk patients, particularly those with underlying renal impairment. He has authored/co-authored over 40 original manuscripts, reviews and chapters and serves on the Executive Committee of a large-scale clinical trial in patients undergoing coronary intervention.
Disclosure information not submitted.
DAPT SELECTION AND DURATION BEFORE AND AFTER PCI
Saturday, March 8, 2025
4:30 PM – 5:30 PM ET
THROMBUS MANAGEMENT AND ANTICOAGULATION
Sunday, March 9, 2025
2:54 PM – 4:25 PM ET
Panel Discussion | Thrombus Management and Anticoagulation
Sunday, March 9, 2025
4:06 PM – 4:25 PM ET
Sunday, March 9, 2025
7:40 PM – 7:50 PM ET
Cangrelor as a Bridge to CABG and Which Antiplatelet Post Cangrelor?
Sunday, March 9, 2025
8:00 PM – 8:10 PM ET
Sunday, March 9, 2025
8:30 PM – 8:45 PM ET
Late-Breaking Clinical Science | Coronary II
Monday, March 10, 2025
9:00 AM – 10:00 AM ET